Stock 688065 CATHAY BIOTECH INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Cathay Biotech Inc.

Equities

688065

CNE100004447

Specialty Chemicals

End-of-day quote Shanghai S.E.
Other stock markets
 03:30:00 26/04/2024 am IST 		5-day change 1st Jan Change
43.51 CNY +5.58% Intraday chart for Cathay Biotech Inc. +8.45% -20.86%
15/04 Cathay Biotech's Q1 Profit to Surge Up to 100%, Revenue to Climb 43%; Shares Up 6% MT
02/04 Tranche Update on Cathay Biotech Inc.'s Equity Buyback Plan announced on August 17, 2023. CI

Valuation

Fiscal Period: December 2020 2021 2022 2023
Capitalization 1 35,439 76,786 35,749 25,383
Enterprise Value (EV) 1 35,439 76,786 35,749 32,074
P/E ratio 72.1 x 127 x 64.5 x 87.3 x
Yield 0.94% - - -
Capitalization / Revenue 23.7 x - 14.6 x 15.2 x
EV / Revenue 23.7 x - 14.6 x 15.2 x
EV / EBITDA 55.1 x - 36.6 x 25.9 x
EV / FCF - - - -
FCF Yield - - - -
Price to Book 3.42 x - 3.27 x 2.87 x
Nbr of stocks (in thousands) 5,83,355 5,83,355 5,83,278 5,83,378
Reference price 2 60.75 131.6 61.29 43.51
Announcement Date 25/02/21 24/02/22 27/02/23 23/02/24
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023
Net sales 1 1,916 1,497 - 2,441 2,114
EBITDA 1 - 642.8 - 978.1 979
EBIT 1 - 522.2 - 708.3 455.5
Operating Margin - 34.88% - 29.01% 21.54%
Earnings before Tax (EBT) 1 - 520.8 - 696 450.2
Net income 1 478.9 457.7 603.6 553.3 367
Net margin 24.99% 30.57% - 22.66% 17.36%
EPS 2 - 0.8429 1.036 0.9500 0.6300
Free Cash Flow - - - - -
FCF margin - - - - -
FCF Conversion (EBITDA) - - - - -
FCF Conversion (Net income) - - - - -
Dividend per Share - 0.5714 - - -
Announcement Date 07/08/20 25/02/21 24/02/22 27/02/23 23/02/24
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023
Net Debt - - - - -
Net Cash position - - - - -
Leverage (Debt/EBITDA) - - - - -
Free Cash Flow - - - - -
ROE (net income / shareholders' equity) - 6.59% - 5.12% 3.31%
ROA (Net income/ Total Assets) - 5.05% - 3.25% 3.2%
Assets 1 - 9,059 - 17,006 17,406
Book Value Per Share 2 - 17.80 - 18.80 19.20
Cash Flow per Share 2 - 0.8800 - 1.380 0.1300
Capex 1 - 763 - 4,198 504
Capex / Sales - 50.97% - 171.98% 16.08%
Announcement Date 07/08/20 25/02/21 24/02/22 27/02/23 23/02/24
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

Company calendar

Sector Industrial Biotechnology Chemicals

1st Jan change Capi.
CATHAY BIOTECH INC. Stock Cathay Biotech Inc.
-20.86% 3.5B
NOVONESIS A/S Stock Novonesis A/S
+5.36% 25.92B
BORREGAARD ASA Stock Borregaard ASA
+10.74% 1.7B
PUYANG HUICHENG ELECTRONIC MATERIAL CO., LTD. Stock Puyang Huicheng Electronic Material Co., Ltd.
-21.15% 563M
HENAN JINDAN LACTIC ACID TECHNOLOGY CO.,LTD. Stock Henan Jindan Lactic Acid Technology Co.,Ltd.
-26.15% 384M
BIO-ON S.P.A. Stock Bio-on S.p.A.
-81.65% 216M
Industrial Biotechnology Chemicals
  1. Stock Market
  2. Equities
  3. 688065 Stock
  4. Financials Cathay Biotech Inc.